[HTML][HTML] The changing epidemiology of human monkeypox—A potential threat? A systematic review
EM Bunge, B Hoet, L Chen, F Lienert… - PLoS neglected …, 2022 - journals.plos.org
Monkeypox, a zoonotic disease caused by an orthopoxvirus, results in a smallpox-like
disease in humans. Since monkeypox in humans was initially diagnosed in 1970 in the …
disease in humans. Since monkeypox in humans was initially diagnosed in 1970 in the …
A systematic literature review of herpes zoster incidence worldwide
D van Oorschot, H Vroling, E Bunge… - Human vaccines & …, 2021 - Taylor & Francis
We conducted a systematic review to characterize the incidence rate of herpes zoster (HZ)
in the general population, specifically in individuals ≥50 years of age. A total of 69 …
in the general population, specifically in individuals ≥50 years of age. A total of 69 …
Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial)
KAM van den Bergh, ML Essink‐Bot, EM Bunge… - Cancer, 2008 - Wiley Online Library
BACKGROUND. Computed tomography (CT) screening is an important new tool for the
early detection of lung cancer. In the current study, the authors assessed the discomfort …
early detection of lung cancer. In the current study, the authors assessed the discomfort …
[HTML][HTML] The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature
S Taylor, E Bunge, M Bakker, X Castellsagué - BMC infectious diseases, 2016 - Springer
Background Human papillomavirus (HPV) vaccines were designed to prevent cervical cancer
in women and their provision remains a major public health need. However, HPV is also a …
in women and their provision remains a major public health need. However, HPV is also a …
A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis
W Kandeil, C van Den Ende, EM Bunge… - Expert review of …, 2020 - Taylor & Francis
Introduction Infants too young to be fully immunized are the most vulnerable to severe
pertussis disease. To close this susceptibility gap, passive infant immunization through …
pertussis disease. To close this susceptibility gap, passive infant immunization through …
Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines–A systematic review
AL Stuurman, C Marano, EM Bunge… - Human vaccines & …, 2017 - Taylor & Francis
The WHO recommends integration of universal mass vaccination (UMV) against hepatitis A
virus (HAV) in national immunization schedules for children aged ≥1 year, if justified on the …
virus (HAV) in national immunization schedules for children aged ≥1 year, if justified on the …
Health-related quality of life in patients with adolescent idiopathic scoliosis after treatment: short-term effects after brace or surgical treatment
EM Bunge, RE Juttmann, M de Kleuver… - European Spine …, 2007 - Springer
For treatment of teenagers with progressive adolescent idiopathic scoliosis in an early stage,
two options are generally considered: treatment with a brace or observation followed by …
two options are generally considered: treatment with a brace or observation followed by …
[HTML][HTML] Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review
…, E Duffell, IK Veldhuijzen, U Petriti, EM Bunge… - …, 2019 - eurosurveillance.org
Background People living with HIV (PLHIV) and people in prison are population groups with
a potentially high risk and/or prevalence of hepatitis B virus (HBV) and hepatitis C virus (…
a potentially high risk and/or prevalence of hepatitis B virus (HBV) and hepatitis C virus (…
Hepatitis A occurrence and outbreaks in Europe over the past two decades: a systematic review
A Andani, E Bunge, G Kassianos… - Journal of Viral …, 2023 - Wiley Online Library
Hepatitis A (HA) is a vaccine‐preventable liver disease with >170 million new cases occurring
yearly. In recent outbreaks in the USA, hospitalization and case‐fatality ratios were >60% …
yearly. In recent outbreaks in the USA, hospitalization and case‐fatality ratios were >60% …
The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience
…, C Marano, A Van Ahee, EM Bunge… - Expert review of …, 2017 - Taylor & Francis
Introduction: Engerix B (GSK HepB, GSK, Belgium) was the first recombinant hepatitis B
virus vaccine to be licensed, and marked its 30 th anniversary in 2016. Vaccination of adult …
virus vaccine to be licensed, and marked its 30 th anniversary in 2016. Vaccination of adult …